DBV Technologies S.A. (EPA:DBV)
France flag France · Delayed Price · Currency is EUR
1.708
+0.030 (1.79%)
Jul 18, 2025, 5:35 PM CET

DBV Technologies Company Description

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.

The company’s product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow’s milk protein allergy and eosinophilic esophagitis.

Its earlier stage research programs include vaccine for the respiratory syncytial virus, potential treatments for inflammatory bowel disease, celiac disease, and type I diabetes.

In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy.

It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers.

DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.

DBV Technologies S.A.
DBV Technologies logo
CountryFrance
Founded2002
IndustryBiotechnology
SectorHealthcare
Employees110
CEODaniel Tassé

Contact Details

Address:
Bâtiment IRO
Châtillon, 92320
France
Phone33 1 55 42 78 78
Websitedbv-technologies.com

Stock Details

Ticker SymbolDBV
ExchangeEuronext Paris
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberFR0010417345
SIC Code2836

Key Executives

NamePosition
Daniel TasséChief Executive Officer and Director
Virginie Simone Jeanine Verrechia Boucinha M.B.A.Chief Financial Officer
Dr. Pharis Mohideen M.D.Chief Medical Officer
Dr. Kevin P. Malobisky M.S., Ph.D., R.A.C.Chief Operations Officer
Michele F. RobertsonChief Legal Officer
Caroline DaniereChief Human Resources Officer and Chief of Staff
Alan KerrSenior Vice President and Head of Global Regulatory Affairs
Pascal WotlingChief External Manufacturing and Supply Chain Officer
Dr. Robert G. Pietrusko Pharm. D., Pharm.D.Chief Regulatory Officer
Katie MatthewsInvestor Relations Officer